Oncology News & Articles

1 Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial The Lancet Oncology - Online First, May 23, 2012    Clinical Article

2 Photodynamic Therapy for Multiple Eruptive Keratoacanthomas Associated With Vemurafenib Treatment for Metastatic Melanoma Archives of Dermatology, May 23, 2012    Clinical Article

3 Bevacizumab-Induced Alterations in Vascular Permeability and Drug Delivery: A Novel Approach to Augment Regional Chemotherapy for In-Transit Melanoma Clinical Cancer Research, May 23, 2012    Clinical Article

4 Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project (Me-Can) British Journal of Dermatology, May 23, 2012

5 Value and prognostic significance of mitotic rate in a retrospective series of pT1 cutaneous malignant melanoma patients Cancer Epidemiology, May 23, 2012

6 Phase I study of RO4929097, a gamma secretase inhibitor of Notch signaling, in patients with refractory metastatic or locally advanced solid tumors Journal of Clinical Oncology, May 23, 2012

7 Randomized, double-blind, placebo-controlled trial of sulindac in individuals at risk for melanoma Cancer, May 23, 2012    Clinical Article

8 Seasonal variations in vitamin D levels in melanoma patients: a single-centre prospective pilot comparative study Journal of the European Academy of Dermatology and Venereology, May 23, 2012

9 International trends in the incidence of malignant melanoma 1953-2008 - are recent generations at higher or lower risk International Journal of Cancer, May 23, 2012

10 Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon-mediated rejection genes International Journal of Cancer, May 23, 2012

11 Prospective study of ultraviolet radiation exposure and risk of cancer in the U.S. International Journal of Cancer, May 23, 2012

12 Role of glutathione S-transferases in melanoma susceptibility: association with GSTP1 rs1695 polymorphism British Journal of Dermatology, May 23, 2012

13 No association of vitamin D metabolism-related polymorphisms and melanoma risk as well as melanoma prognosis: a case-control study Archives of Dermatological Research, May 23, 2012    Clinical Article

14 Elevated expression of Rad18 regulates melanoma cell proliferation Pigment Cell & Melanoma Research, May 23, 2012

15 Ipilimumab: In Previously Treated Patients with Advanced Melanoma BioDrugs, May 23, 2012

16 Prospective analysis of association between use of statins and melanoma risk in the Womens Health Initiative Cancer, May 7, 2012    Clinical Article

17 Comparison of the use and results of sentinel lymph node biopsy in children and young adults with melanoma Cancer, May 7, 2012

18 Superior outcome of women with stage I/II cutaneous melanoma: pooled analysis of four European Organisation for Research and Treatment of Cancer Phase III Trials Journal of Clinical Oncology, May 7, 2012    Clinical Article

19 Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma Cancer, May 7, 2012

20 Malignant melanoma, breast cancer and other cancers in patients with Parkinsons disease International Journal of Cancer, May 7, 2012

21 Dissection of T-cell Antigen Specificity in Human Melanoma Cancer Research, May 7, 2012

22 Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase British Journal of Cancer, May 7, 2012

23 Functional T Cells Targeting NY-ESO-1 or Melan-A Are Predictive for Survival of Patients With Distant Melanoma Metastasis Journal of Clinical Oncology, May 7, 2012

24 NRAS mutation status is an independent prognostic factor in metastatic melanoma Cancer, May 7, 2012

25 MC1R genotypes and risk of melanoma before age 40 years: A population-based case-control-family study International Journal of Cancer, May 7, 2012

26 Use of Tanning Beds and Incidence of Skin Cancer Journal of Clinical Oncology, April 21, 2012    Clinical Article

27 Tattoos, inks, and cancer The Lancet Oncology, April 21, 2012

28 Lipocalin-type prostaglandin D synthase as a marker for the proliferative potential of melanocyte-lineage cells in the human skin Journal of Dermatology, April 21, 2012

29 Melanoma with unknown primary: report and analysis of 24 patients Medical Oncology, April 21, 2012

30 Adjunct primer for the use of national comprehensive cancer network guidelines for the surgical management of cutaneous malignant melanoma patients World Journal of Surgical Oncology, April 21, 2012

31 Role and Regulation of STAT3 Phosphorylation at Ser727 in Melanocytes and Melanoma Cells Journal of Investigative Dermatology, April 21, 2012

32 Evaluation of different methods in the follow-up of patients with indolent types of primary cutaneous lymphomas British Journal of Dermatology, April 21, 2012

33 Mcl-1 determines the imiquimod-induced apoptosis but not imiquimod-induced autophagy in skin cancer cells Journal of Dermatological Science, April 21, 2012

34 The metastatic microenvironment. Brain-derived soluble factors alter the malignant phenotype of cutaneous and brain- metastasizing melanoma cells International Journal of Cancer, April 21, 2012

35 Promoter methylation of aminopeptidase N/CD13 in malignant melanoma Carcinogenesis, April 21, 2012

36 P75 Nerve Growth Factor Receptor as a Useful Marker to Distinguish Spindle Cell Melanoma From Other Spindle Cell Neoplasms of Sun-Damaged Skin The American Journal of Dermatopathology, April 21, 2012

37 A decreased ratio between serum levels of the antagonistic angiopoietins 1 and 2 indicates tumour progression of malignant melanoma Archives of Dermatological Research, April 21, 2012

38 CTLA-4 Blockade with Ipilimumab: Long-term Follow-up of 177 Patients with Metastatic Melanoma Clinical Cancer Research, April 5, 2012    Clinical Article

39 Prospective analysis of association between use of statins and melanoma risk in the womens health initiative Cancer, April 5, 2012    Clinical Article

40 Obesity and the incidence of skin cancer in US Caucasians Cancer Causes and Control, April 5, 2012    Clinical Article

41 Single versus multiple primary melanomas Cancer, April 5, 2012

42 Histological ulceration as a prognostic factor in cutaneous melanoma Clinical and Translational Oncology, April 5, 2012

43 Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial Cancer Immunology, Immunotherapy, April 5, 2012

44 Identification of biomarkers to distinguish clear cell sarcoma from malignant melanoma Human Pathology, April 5, 2012

45 Inherited variants in the MC1R gene and survival from cutaneous melanoma: a BioGenoMEL study Pigment Cell & Melanoma Research, April 5, 2012

46 Risk Factors for Malignant Melanoma in White and Non-White/Non-African American Populations Cancer Prevention Research, April 5, 2012

47 The Clinical Effect of the Inhibitor of Apopotosis Protein Livin in Melanoma Oncology (Karger), April 5, 2012

48 MAPK and PI3K/AKT mediated YB-1 activation promotes melanoma cell proliferation which is counteracted by an autoregulatory loop Experimental Dermatology, April 5, 2012

49 Dermoscopy of Lentigo Maligna Melanoma: Report of 125 Cases British Journal of Dermatology, April 5, 2012

50 Dickkopf-1 inhibits the invasive activity of melanoma cells Clinical and Experimental Dermatology, April 5, 2012

51 AIM1 and LINE-1 Epigenetic Aberrations in Tumor and Serum Relate to Melanoma Progression and Disease Outcome Journal of Investigative Dermatology, April 5, 2012

52 Population-Based 20-Year Survival Among People Diagnosed With Thin Melanomas in Queensland, Australia Journal of Clinical Oncology, April 5, 2012

53 Fluorescence in-situ hybridization analysis for melanoma diagnosis Histopathology, April 5, 2012

54 Association of Vitamin A and Carotenoid Intake with Melanoma Risk in a Large Prospective Cohort Journal of Investigative Dermatology, March 20, 2012

55 Sunitinib Therapy for Melanoma Patients with KIT Mutations Clinical Cancer Research, March 20, 2012    Clinical Article

56 The role of surgery in the treatment of colorectal metastases from primary skin melanoma Colorectal Disease, March 20, 2012

57 Optimization of EPR imaging for visualization of human skin melanoma in various stages of invasion Experimental Dermatology, March 20, 2012

58 Sequential Local Injection of Low-Dose Interferon-Beta for Maintenance Therapy in Stage II and III Melanoma Oncology (Karger), March 20, 2012

59 Evaluation of heparanase and matrix metalloproteinase-9 in patients with cutaneous malignant melanoma Journal of Dermatology, March 20, 2012

60 Methylene blue photodynamic therapy in malignant melanoma decreases expression of proliferating cell nuclear antigen and heparanases Clinical and Experimental Dermatology, March 20, 2012    Clinical Article

61 MHC class I molecules act as tumor suppressor genes regulating the cell cycle gene expression, invasion and intrinsic tumorigenicity of melanoma cells Carcinogenesis, March 20, 2012

62 A UVR-Induced G2-Phase Checkpoint Response to ssDNA Gaps Produced by Replication Fork Bypass of Unrepaired Lesions Is Defective in Melanoma Journal of Investigative Dermatology, March 20, 2012

63 Assessment of association between BRAF-V600E mutation status in melanomas and clinical response to ipilimumab Cancer Immunology, Immunotherapy, March 20, 2012

64 Immunotype and Immunohistologic Characteristics of Tumor-Infiltrating Immune Cells Are Associated with Clinical Outcome in Metastatic Melanoma Cancer Research, March 20, 2012

65 New Strategies in Melanoma: Molecular Testing in Advanced Disease Clinical Cancer Research, March 20, 2012

66 The cutaneous manifestations of metastatic malignant melanoma International Journal of Dermatology, March 4, 2012    Clinical Article

67 Selective BRAF inhibitors induce marked T-cell infiltration into human metastatic melanoma Clinical Cancer Research, March 4, 2012    Clinical Article

68 Chronic Lymphocytic Leukemia Is Associated With Decreased Survival of Patients With Malignant Melanoma and Merkel Cell Carcinoma in a SEER Population-Based Study Journal of Clinical Oncology, March 4, 2012
Exclusive Author Commentary

69 Survival in BRAF V600-Mutant Advanced Melanoma Treated with Vemurafenib New England Journal of Medicine, March 4, 2012

70 Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival Full Text BMC Cancer, March 4, 2012

Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversies Journal of Thoracic Disease, 08/05/2011

1 Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP Protocol B-24 Journal of Clinical Oncology, April 9, 2012

2 The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal Journal of Gastrointestinal Oncology, April 16, 2012    Free full text

3 Preoperative chemotherapy plus trastuzumab, lapatinib, or both in human epidermal growth factor receptor 2-positive operable breast cancer: Results of the randomized phase III CHER-LB study Journal of Clinical Oncology, April 12, 2012

4 Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancer European Journal of Cancer, April 2, 2012

5 Metformin use is associated with better survival of diabetic patients with pancreatic cancer Clinical Cancer Research, April 4, 2012

6 Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study The Lancet, April 24, 2012

7 Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials The Lancet Oncology - Online First, March 22, 2012

8 Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data Journal of Clinical Oncology, April 5, 2012

9 Rapid-onset hypogonadism secondary to crizotinib use in men with metastatic nonsmall cell lung cancer Cancer, April 6, 2012

10 Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial The Lancet Oncology - Online First, March 28, 2012

11 Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial The Lancet - Early Online Publication, April 5, 2012

12 The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus International Journal of Cancer, April 26, 2012

13 Infectious complications of chemotherapy in clinically aggressive mature B and T cell lymphomas European Journal of Internal Medicine , April 3, 2012

14 Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer JAMA, April 19, 2012

15 Association between tamoxifen treatment and diabetes Cancer, April 16, 2012

16 The utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancer International Journal of Cancer, April 23, 2012

17 Pneumonitis associated with mTOR inhibitors therapy in patients with metastatic renal cell carcinoma: Incidence, radiographic findings and correlation with clinical outcome European Journal of Cancer, April 11, 2012

18 Digoxin use and the risk of cancers of the corpus uteri, ovary and cervix International Journal of Cancer, April 18, 2012

19 Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trial The Lancet Oncology - Online First, April 20, 2012

20 Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C) Journal of Clinical Oncology, April 9, 2012